drugset / Trial / NCT00055484

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

NCT00055484

Phase 2 Completed 204 enrolled Elan Pharmaceuticals
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.

Timeline

Start
2002-03
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 150 mg
Subject Zonisamide Other / unclassified 300 mg

Indications